Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of SUPN will decline by -9.47% over the next 2 Weeks and hit $44.59 by Monday, April 6, 2026. In that time frame, SUPN's share price is expected to range between $42.97 and $46.26.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 6, 2026 | 42.97 | 44.59 | 46.26 |
| Apr 3, 2026 | 43.44 | 44.99 | 46.71 |
| Apr 2, 2026 | 43.67 | 45.21 | 46.73 |
| Apr 1, 2026 | 44.62 | 45.99 | 47.62 |
| Mar 31, 2026 | 44.67 | 46.25 | 47.81 |
| Mar 30, 2026 | 44.87 | 46.45 | 47.97 |
| Mar 27, 2026 | 45.35 | 46.85 | 48.33 |
| Mar 26, 2026 | 45.46 | 47.07 | 48.68 |
| Mar 25, 2026 | 46.34 | 47.85 | 49.36 |
| Mar 24, 2026 | 46.68 | 48.11 | 49.66 |
SUPN shares rose +0.26% in Tuesday, March 24, 2026's trading session, rising from a previous close of $49.25 to move at $49.38. The stock demonstrated notable intraday movement (see SUPN's key stats for a full breakdown), fluctuating between $48.24 and $49.87, a +3.37% trading range. While recent weeks have seen some volatility, SUPN has managed to secure a -7.22% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 548.68K shares changing hands, 282.47K fewer than the previous session. This amounted to $27.09M in total market activity.
Will SUPN Continue Its Downward Trend?
According to analyst ratings and projections for SUPN, Supernus Pharmaceuticals, Inc. shares are anticipated to decrease by -6.75%, potentially reaching $46.26 per share by April 6, 2026. Short-term technical indicators currently suggest a neutral sentiment for SUPN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the SUPN stock forecast, now is not the best time to buy SUPN stock because its current trading price is +10.75% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on SUPN covering social and institutional perspectives.
SUPN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into SUPN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.99% to 44.72%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.83%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.31%, maintains a neutral outlook for the long term. Insights into SUPN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Supernus Pharmaceuticals Short-Term Forecasts
SUPN Forecast For Next 5 Days
Our algorithm anticipates Supernus Pharmaceuticals (SUPN) stock could hit $48.33 by Mar 31, 2026. This represents a -2.12% fall from today's price, following a -3.00% change over the past five days.
SUPN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Supernus Pharmaceuticals, Inc. (SUPN) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $49.74, which would mean a +0.73% increase from the current price of $49.38. Projections for this period range from a high of $54.01 to a low of $45.14.
SUPN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Supernus Pharmaceuticals's price over the next three months point to a drop. SUPN stock is expected to peak at $52.62 on Jun 17, 2026 after potentially dipping to $44.45 on Apr 15, 2026. On average, SUPN is likely to trade around $48.89 in the coming 90 days.
Supernus Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Supernus Pharmaceuticals (SUPN) is expected to trade between $44.45 and $57.60 throughout 2026. This would result in an average price of $50.26, potentially offering investors a +1.78% return from current levels.
Supernus Pharmaceuticals, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Supernus Pharmaceuticals, Inc. (SUPN) is positioned to show a strong performance in March 2026. The price is predicted to move between $45.57 and $51.28, settling at an average of $48.57. This could translate to a -1.64% loss.
April 2026
Based on current market signals, Supernus Pharmaceuticals, Inc. is projected to trend april 2026. We forecast a trading range from $44.45 to $51.96, with a likely average price of $48.53. Investors could expect a potential return of -1.72%.
May 2026
Our predictive algorithms indicate Supernus Pharmaceuticals, Inc. stock may see a shift in May 2026. The expected range spans $45.93–$51.93, with an average target of $48.76. This represents a cautious outlook and a possible loss of -1.26%.
June 2026
Analyzing established trends, Supernus Pharmaceuticals, Inc. looks set to move in June 2026. Projections place the stock between $46.14 and $52.62, averaging around $49.57. This suggests a +0.38% gain from current levels.
July 2026
Market indicators suggest Supernus Pharmaceuticals, Inc. could experience notable changes during July 2026. Prices could fluctuate within $47.28 to $53.32, with a midpoint forecast of $50.25. The stock might deliver a +1.76% gain.
August 2026
Forecasting for August 2026, models estimate that Supernus Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $47.49 and $53.89, averaging $50.65. This signals a positive trajectory with potential returns around +2.57%.
September 2026
According to our latest forecast models, Supernus Pharmaceuticals, Inc. (SUPN) is positioned to show a strong performance in September 2026. The price is predicted to move between $46.78 and $54.17, settling at an average of $50.44. This could translate to a +2.15% gain.
October 2026
Based on current market signals, Supernus Pharmaceuticals, Inc. is projected to trend october 2026. We forecast a trading range from $47.64 to $54.03, with a likely average price of $50.60. Investors could expect a potential return of +2.47%.
November 2026
Our predictive algorithms indicate Supernus Pharmaceuticals, Inc. stock may see a shift in November 2026. The expected range spans $48.64–$57.60, with an average target of $51.76. This represents a positive outlook and a possible gain of +4.82%.
December 2026
Analyzing established trends, Supernus Pharmaceuticals, Inc. looks set to move in December 2026. Projections place the stock between $49.05 and $55.30, averaging around $52.20. This suggests a +5.71% gain from current levels.
January 2027
Market indicators suggest Supernus Pharmaceuticals, Inc. could experience notable changes during January 2027. Prices could fluctuate within $49.62 to $55.73, with a midpoint forecast of $52.61. The stock might deliver a +6.54% gain.
February 2027
Forecasting for February 2027, models estimate that Supernus Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $48.55 and $56.01, averaging $52.32. This signals a positive trajectory with potential returns around +5.95%.
March 2027
According to our latest forecast models, Supernus Pharmaceuticals, Inc. (SUPN) is positioned to show a strong performance in March 2027. The price is predicted to move between $49.65 and $55.69, settling at an average of $52.57. This could translate to a +6.46% gain.
SUPN's history of dividends and stock splits also plays a role in long-term investor confidence.